Marica Meroni

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Venues

International journal of molecular sciences

Biomedicines

Nutrients

Cancers

University of Milan

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Milan Jan 01 2019 - Dec 31 2020

Italy

Assegnisti di ricerca

University of Milan Nov 01 2014 - Feb 23 2018

Italy

Dottorandi

Publications

Miriam Longo, Erika Paolini, Pietro Di Benedetto, Elena Tomassini, Marica Meroni, Paola Dongiovanni
DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application. International journal of molecular sciences 25 (16) (2024)
Miriam Longo, Erika Paolini, Pietro Di Benedetto, Elena Tomassini, Marica Meroni, Paola Dongiovanni
DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application. International journal of molecular sciences 25 (16) (2024)
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 11 (2) (2023)
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 11 (2) (2023)
Marica Meroni, Paola Dongiovanni
PNPLA3 rs738409 Genetic Variant Inversely Correlates with Platelet Count, Thereby Affecting the Performance of Noninvasive Scores of Hepatic Fibrosis. International journal of molecular sciences 24 (20) (2023)
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 11 (2) (2023)
Suraj J Patel, Nan Liu, Sam Piaker, Anton Gulko, Maynara L Andrade, Frankie D Heyward, Tyler Sermersheim, Nufar Edinger, Harini Srinivasan, Margo P Emont, Gregory P Westcott, Jay Luther, Raymond T Chung, Shuai Yan, Manju Kumari, Reeby Thomas, Yann Deleye, Andre Tchernof, Phillip J White, Guido A Baselli, Marica Meroni, Dario F De Jesus, Rasheed Ahmad, Rohit N Kulkarni, Luca Vittorio Valenti, Linus T Tsai, Evan D Rosen
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b . Science translational medicine 14 (637) (2022)
Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni
Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution. Biomedicines 10 (3) (2022)
Annalisa Cespiati, Marica Meroni, Rosa Lombardi, Giovanna Oberti, Paola Dongiovanni, Anna Ludovica Fracanzani
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 10 (1) (2022)
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. Biomedicines 9 (11) (2021)
Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC. International journal of molecular sciences 22 (8) (2021)
Miriam Longo, Erika Paolini, Marica Meroni, Lorena Duca, Irene Motta, Anna Ludovica Fracanzani, Elena Di Pierro, Paola Dongiovanni
α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study. Diagnostics (Basel, Switzerland) 11 (9) (2021)
Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni
Genetics Is of the Essence to Face NAFLD. Biomedicines 9 (10) (2021)
Marica Meroni, Miriam Longo, Erika Paolini, Anna Alisi, Luca Miele, Emilia Rita De Caro, Giuseppina Pisano, Marco Maggioni, Giorgio Soardo, Luca Vittorio Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. Cancers 13 (8) (2021)
Raffaela Rametta, Marica Meroni, Paola Dongiovanni
From Environment to Genome and Back: A Lesson from HFE Mutations. International journal of molecular sciences 21 (10) (2020)
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni
Nutrition and Genetics in NAFLD: The Perfect Binomium. International journal of molecular sciences 21 (8) (2020)
Marica Meroni, Miriam Longo, Paola Dongiovanni
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients 11 (11) (2019)
Marica Meroni, Miriam Longo, Veronica Erconi, Luca Vittorio Valenti, Stefano Gatti, Anna Ludovica Fracanzani, Paola Dongiovanni
mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance. Nutrients 11 (11) (2019)
Marica Meroni, Miriam Longo, Paola Dongiovanni
Alcohol or Gut Microbiota: Who Is the Guilty? International journal of molecular sciences 20 (18) (2019)
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani
miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. International journal of molecular sciences 19 (12) (2018)
Marica Meroni, Miriam Longo, Raffaela Rametta, Paola Dongiovanni
Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. International journal of molecular sciences 19 (12) (2018)

Marica Meroni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marica Meroni